Bergio International (BRGO) 10-Q 11 Jan 19 2018 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2018	Jan. 10, 2019
Details
Registrant Name	Bergio International, Inc.
Registrant CIK	1,431,074
SEC Form	10-Q
Period End date	Sep. 30, 2018
Fiscal Year End	--12-31
Trading Symbol	brgo
Tax Identification Number (TIN)	271,338,257
Number of common stock shares outstanding		5,391,410,729
Filer Category	Non-accelerated Filer
Current with reporting	Yes
Small Business	true
Emerging Growth Company	false
Amendment Flag	false
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q3
Entity Incorporation, State Country Name	Delaware

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Current assets:
Cash	$ 0	$ 21,721
Accounts receivable, net of allowance for doubtful accounts of $-0- at September 30, 2018 and $76,227 at December 31, 2017	38,599	61,511
Inventories	1,107,987	1,178,646
Total current assets	1,146,586	1,261,878
Property and equipment, net	167,239	243,420
Investment in unconsolidated affiliate	5,828	5,828
Total assets	1,319,653	1,511,126
Current Liabilities:
Accounts payable and accrued liabilities	245,148	250,796
Bank lines of credit, net	0	14,700
Loan payable	100,000	0
Convertible debt, net	419,568	437,781
Advances from Principal Executive Officer and accrued interest	227,860	459,636
Deferred compensation - CEO	0	628,309
Total current liabilities	992,576	1,791,222
Long-term Liabilities:
Deferred compensation, CEO, long-term portion	755,559	0
Advances from Principal Executive Officer and accrued interest	244,441	0
Total long-term liabilities	1,000,000	0
Total Liabilities	1,992,576	1,791,222
Commitments and contingencies	0	0
Shareholders' deficit:
Series A Preferred stock value	0	0
Common stock value	49,074	46,218
Additional paid-in capital	7,899,568	7,881,784
Accumulated deficit	(8,621,565)	(8,208,098)
Total stockholders' deficit	(672,923)	(280,096)
Total liabilities and stockholders' deficit	$ 1,319,653	$ 1,511,126

CONSOLIDATED BALANCE SHEETS - P

CONSOLIDATED BALANCE SHEETS - Parenthetical - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Details
Allowance for Doubtful Accounts Receivable, Current	$ 0	$ 76,227
Preferred Stock, Par or Stated Value Per Share	$ 0.00001	$ 0.00001
Preferred Stock, Shares Authorized	51	51
Preferred Stock, Shares Outstanding	51	51
Common Stock, Par or Stated Value Per Share	$ 0.00001	$ 0.00001
Common Stock, Shares Authorized	6,000,000,000	6,000,000,000
Common Stock, Shares, Outstanding	4,907,602,947	4,622,047,391
Common Stock, Shares, Issued	4,907,602,947	4,622,047,391

CONSOLIDATED STATEMENT OF OPERA

CONSOLIDATED STATEMENT OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Details
Sales, Net	$ 62,313	$ 225,980	$ 272,184	$ 408,648
Cost of Sales	73,174	157,788	255,253	236,069
Gross Profit	(10,861)	68,192	16,931	172,579
Selling, General and Administrative Expenses:
Selling, General and Administrative expenses	123,102	118,037	349,042	313,226
Total Selling, General and Administrative Expenses	123,102	118,037	349,042	313,226
(Loss) Income from Operations	(133,963)	(49,485)	(332,111)	(140,647)
Other Income (expense):
Interest Expense	(18,318)	0	(81,356)	(58,103)
Interest Income	0	2,074	0	0
Change in Fair Value of Derivatives	0	(5,340)	0	14,724
Gain (loss) on sale of asset	0	48,480	0	48,480
Gain (loss) on extinguishment of debt	0	36,953	0	36,279
Total Other Expense	(18,318)	82,167	(81,356)	41,380
Loss before income taxes	(152,281)	32,322	(413,467)	(99,267)
Provision for Income Taxes	0	0	0	0
Net Income (loss)	$ (152,281)	$ 32,322	$ (413,467)	$ (99,267)
Net Loss per Common Share:
Basic	$ 0	$ 0	$ 0	$ 0
Fully diluted	$ 0	$ 0	$ 0	$ 0
Weighted Average Shares:
Basic	4,907,602,947	2,588,323,113	4,833,532,943	2,306,206,458
Diluted	4,907,602,947	10,591,290,696	4,833,532,943	2,306,206,458

CONSOLIDATED STATEMENT OF CHANG

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDER'S DEFICIT (UNAUDITED) - USD ($)	Common Stock	Additional Paid-in Capital	Retained Earnings	Noncontrolling Interest	Total
Equity Balance at Dec. 31, 2016	$ 18,366	$ 7,531,256	$ (7,801,231)	$ (21,242)	$ (272,851)
Equity Balance, Shares at Dec. 31, 2016	1,836,846,489
Issuance of stock for debt conversion, value	$ 23,902	143,825	0	0	167,727
Issuance of stock for debt conversion, shares issued	2,390,200,902
Issuance of stock for accounts payable	$ 1,850	16,650	0	0	18,500
Issuance of stock for accounts payable, shares issued	185,000,000
Issuance of common stock for services	$ 2,100	18,900	0	0	21,000
Issuance of stock for services, shares issued	210,000,000
Non-controlling interest	$ 0	171,153	(192,395)	21,242	0
Net loss	$ 0	0	(214,472)		(214,472)
Equity Balance, Shares at Dec. 31, 2017	4,622,047,391
Equity Balance at Dec. 31, 2017	$ 46,218	7,881,784	(8,208,098)	0	(280,096)
Issuance of stock for debt conversion, value	$ 2,856	17,784	0	0	20,640
Issuance of stock for debt conversion, shares issued	285,555,556
Net loss	$ 0	0	(413,467)	0	(413,467)
Equity Balance, Shares at Sep. 30, 2018	4,907,602,947
Equity Balance at Sep. 30, 2018	$ 49,074	$ 7,899,568	$ (8,621,565)	$ 0	$ (672,923)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Operating activities:
Net Income (loss)	$ (413,467)	$ (99,267)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	76,181	77,497
Gain (loss) on extinguishment of debt	0	(36,279)
Gain (loss) on sale of asset	0	(48,480)
Change in Fair Value of Derivatives	0	(14,724)
Provision for bad debts	0	(7,175)
Changes in operating assets and liabilities:
(Decrease) increase in accounts receivable	22,912	(42,810)
Decrease in inventory	70,659	62,791
Increase in deferred compensation	127,250	131,250
Increase in accounts payable and accrued liabilities	(3,221)	34,898
Net cash used in operating activities	(119,686)	57,701
Investing activities:
Proceeds from sale of RS Fisher	0	20,527
Net cash provided by investing activities	0	20,527
Financing activities:
Proceeds from loan	100,000	0
Advances of bank lines of credit, net	0	7,202
Repayment of bank lines of credit, net	(14,700)	0
Repayments to Principal Executive Officer, net	0	(93,933)
Advances from Principal Executive Officer, net	12,665	0
Net (used in) cash provided by financing activities	97,965	(86,731)
Net change in cash	(21,721)	(8,503)
Cash - beginning of periods	21,721	21,662
Cash - end of periods	0	13,159
Supplemental disclosures of cash flow information:
Cash paid for interest	0	21,396
Cash paid for income taxes	0	0
Supplemental disclosure of non-cash investing and financing activities:
Issuance of common stock for convertible debt, accrued interest and accounts payable	$ 20,640	$ 48,261

Nature of Operations and Basis

Nature of Operations and Basis of Presentation	9 Months Ended
	Sep. 30, 2018
Notes
Nature of Operations and Basis of Presentation	Note 1 - Nature of Operations and Basis of Presentation Bergio International, Inc. (the “Company”) was incorporated in the State of Delaware on July 24, 2007 under the name Alba Mineral Exploration, Inc. On October 21, 2009, as a result of a Share Exchange Agreement, the corporation’s name was changed to Bergio International, Inc. The Company is engaged in the product design, manufacturing, distribution of fine jewelry primarily in the United States and is headquartered in Fairfield, New Jersey. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments necessary consisting of normal recurring adjustments to present fairly the financial position of the Company as of September 30, 2018, the results of operations for the three and nine months ended September 30, 2018 and 2017, and statements of cash flows for the nine months ended September 30, 2018 and 2017. These results are not necessarily indicative of the results to be expected for the full year. The financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include disclosures normally made in an Annual Report on Form 10-K. The December 31, 2017 balance sheet included herein was derived from the audited financial statements included in the Company’s Annual Report on Form 10-K as of that date. Accordingly, the financial statements included herein should be reviewed in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2017, as filed with the Securities and Exchange Commission (“SEC”) on October 22, 2018 (the “Annual Report”).

Going Concern Disclosure

Going Concern Disclosure	9 Months Ended
	Sep. 30, 2018
Notes
Going Concern Disclosure	Note 2 - Going Concern The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplates continuation of the Company as a going concern. The Company has suffered recurring losses, and has an accumulated deficit of $8,621,565 of September 30, 2018. As of September 30, 2018, the Company had $419,568 in convertible debentures which are currently due and the Company is currently negotiating terms with the holders of these debentures. At September 30, 2018, the Company also had a stockholders’ deficit of $672,923. These factors raise substantial doubt about the Company's ability to continue as a going concern. The recoverability of a major portion of the recorded asset amounts shown in the accompanying consolidated balance sheet is dependent upon continued operations of the Company, which in turn, is dependent upon the Company's ability to raise capital and/or generate positive cash flows from operations. It is our intention to establish Bergio as a holding company for the purpose of establishing retails stores worldwide. Our branded product lines are products and/or collections designed by our designer and CEO Berge Abajian and will be the centerpiece of our retail stores. We also intend to complement our own quality-designed jewelry with other products and our own specially-designed handbags. This is in line with our strategy and belief that a brand name can create an association with innovation, design and quality which helps add value to the individual products as well as facilitate the introduction of new products. It is our intention to open elegant stores in “high-end” areas and provide excellent service in our stores which will be staffed with knowledgeable professionals. We also intend to sell our products on a wholesale basis to limited customers. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that might be necessary in the event the Company cannot continue in existence.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2018
Notes
Summary of Significant Accounting Policies	Note 3 - Summary of Significant Accounting Policies Principles of Consolidation The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States, and include the Company and its wholly-owned subsidiary. All significant inter-company accounts and transactions have been eliminated. During the nine months ended September 30, 2018, there have been no other material changes in the Company’s significant accounting policies to those previously disclosed in the Company’s Annual Report. The Company evaluated subsequent events, which are events or transactions that occurred after September 30, 2018 through the issuance of the accompanying financial statements.

Net Loss Per Share Disclosure

Net Loss Per Share Disclosure	9 Months Ended
	Sep. 30, 2018
Notes
Net Loss Per Share Disclosure	Note 4 - Net Loss per Share Basic earnings (loss) per share includes no dilution and is computed by dividing earnings available to common stockholders by the weighted average number of common shares outstanding for the period. Dilutive earnings per share reflect the potential dilution of securities that could occur through the effect of common shares issuable upon the exercise of stock options, warrants and convertible securities. Basic net loss per share equaled the diluted loss per share for the three and nine months ended September 30, 2018 and 2017, since the effect of shares potentially issuable upon the exercise or conversion was anti-dilutive. Equity instruments that may dilute earnings per share in the future are listed in Note 6 below. For the three and nine months ended September 30, 2018, 6,162,876,190 shares issuable upon the conversion of convertible debt were not included in the computation of diluted net loss because their inclusion would be anti-dilutive. For the nine months ended September 30, 2017, 8,002,967,583 shares issuable upon the conversion of convertible debt were not included in the computation of diluted net loss because their inclusion would be anti-dilutive. The following table sets forth the computation of earnings per share: Three Months Ended Nine Months Ended September 30, 2018 September 30, 2017 September 30, 2018 September 30, 2018 Basic net income (loss) per share computation: Net income (loss) $ (152,281 $ 32,322 $ (413,467) $ (99,267)) Weighted-average common shares outstanding 4,907,602,947 2,588,323,113 4,833,532,943 2,306,206,458 Basic net income (loss) per share $ (0.00) $ (0.00) $ (0.00) $ (0.00) Diluted net income (loss) per share computation: Net income (loss) $ (152,281) $ 32,322 $ (413,467) $ (92,267) Weighted-average common shares outstanding 4,907,602,947 2,558,323,113 4,833,532,943 2,306,206,458 Incremental shares attributable to the shares issuable upon conversion of convertible debt - 8,002,967,583 - - Total adjusted weighted-average shares 4,907,602,947 10,591,290,696 4,833,532,943 2,306,206,458 Diluted net income (loss) per share $ (0.00) $ (0.00) $ (0.00) $ (0.00)

New Authoritative Accounting Gu

New Authoritative Accounting Guidance	9 Months Ended
	Sep. 30, 2018
Notes
New Authoritative Accounting Guidance	5 - New Authoritative Accounting Guidance In May 2014, the FASB issued ASU 2014-09 - Revenue from Contracts with Customers, to clarify the principles of recognizing revenue and create common revenue recognition guidance between U.S. GAAP and International Financial Reporting Standards. The core principle of the guidance is that a company should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. In doing so, companies need to use more judgment and make more estimates than under previous guidance. These may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. In August 2015, the FASB issued ASU 2015-14 - Revenue from Contracts with Customers: Deferral of the Effective Date, deferring the effective date of ASU 2014-09 for one year to interim and annual reporting periods beginning after December 15, 2017. Early adoption was also permitted as of the original effective date (interim and annual periods beginning after December 15, 2016) and full or modified retrospective application was permitted. Subsequently, the FASB issued a number of ASU's amending ASU 2014-09 and providing further guidance related to revenue recognition, which management evaluated. The effective date and transition requirements for these amendments are the same as ASU 2014-09, as amended by ASU 2015-14. Management adopted this guidance on January 1, 2018 using the modified retrospective approach. The impact of the adoption of ASU 2014-09 on the Company's condensed consolidated financial statements is as follows: The Company's revenue is primarily generated from the sale of finished products to customers (primarily through the retail, e-commerce or wholesale channels). The Company's performance obligations underlying such sales, and the timing of revenue recognition related thereto, remain substantially unchanged following the adoption of this ASU. In August 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-15, Presentation of Financial Statements - Going Concern to provide guidance about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern. The guidance requires management to assess whether there are conditions or events, considered in the aggregate, that raise substantial doubt about an entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. When management identifies such conditions or events, a footnote disclosure is required to disclose their nature, as well as management’s plans to alleviate the substantial doubt to continue as a going concern. The standard became effective for our fiscal year end 2017 and did not have an impact on the consolidated financial statements. No other recently issued accounting pronouncements had or are expected to have a material impact on the Company’s condensed consolidated financial statements.

Bank Lines of Credit Disclosure

Bank Lines of Credit Disclosure	9 Months Ended
	Sep. 30, 2018
Notes
Bank Lines of Credit Disclosure	Note 6 - Bank Lines of Credit At December 31, 2017, an amount of $323,855 was reclassified from Bank lines of credit and $2,000 from accounts payable and accrued liabilities to Advances from principal executive officer and accrued interest to reflect the guaranty of these loans by the principal executive officer. The Company had no outstanding credit card at September 30 2018, which was fully paid during the first quarter of 2018. Bank lines of credit consist of the following: September 30, December 31, 2018 2017 The Company had one unsecured credit card, minimum payments of principal and interest are due monthly at the credit card’s annual interest rate. At December 31, 2017, the interest rate charged was approximately 9.3%. $ - $ 14,700 Current maturities included in current liabilities $ - $ 14,700

Convertible Debt Disclosure

Convertible Debt Disclosure	9 Months Ended
	Sep. 30, 2018
Notes
Convertible Debt Disclosure	Note 7 - Convertible Debt Fife, Typenex and Iliad In December 2012, the Company entered into a $325,000 convertible note with Fife consisting of three tranches to be drawn down with the first tranche totaling $125,000, including $25,000 in loan costs and additional two tranches totaling $200,000. The note bears a 5% annual interest rate and matures eighteen months from the date of issuance. The note is convertible into shares of the Company’s common stock based on 70% of the average of the three lowest closing prices of the common stock for the proceeding 15 consecutive trading days immediately prior to the conversion. During 2013, the conversion price was fixed at $0.005 per share. As of December 31, 2012, the Company only drew down the first tranche totaling $125,000. On February 11, 2013, April 5, 2013, April 23, 2013, and July 1, 2013, the Company drew down an additional $250,000. On June 5, 2014, the Company, Fife, Typenex and Iliad Research and Trading, LLP (“Iliad”) entered into an Assignment and Assumption Agreement and Note Purchase Agreement (the “Note Purchase Agreement”) whereby Iliad acquired all of Fife’s and Typenex’s right, title, obligations and interest in, to and arising under the Company Notes (as defined in the Note Purchase Agreement) and the Note Purchase Documents (as defined in the Note Purchase Agreement). On October 17, 2014, the Company entered into a financing arrangement with Iliad to provide additional financing in the amount of up to $450,000 through the issuance of a Secured Convertible Promissory Note (the “Note”). The Company agreed to cover Iliad’s legal, accounting and other related fees in the amount of $5,000, which is included in the principal balance of the Note. The Note will accrue interest at the rate of 8% per annum until the Note is paid in full. Monies are to be drawn in eight tranches with the initial tranche in the amount of $105,000, and the remaining balance of $350,000 in seven tranches of $50,000 each. The Company drew down the initial tranche on October 17, 2014. The Note has a maturity date of July 17, 2016. The Company continues to negotiate with the lender. Beginning six months after October 17, 2014 and on the same day each month thereafter, the Company shall make an installment payment, based upon the unpaid balance. At the option of the Company, payments may be made in cash or by converting the installment amount into shares of the Company’s common stock. The conversion price is equal to the lesser of (i) $0.0005 per share and (ii) 67.5% of the average of the three lowest closing bid prices in the 15 trading days immediately preceding the conversion. The Company has the right to prepay the Note at 135% of the outstanding balance at the time of prepayment. During the nine months ended September 30, 2018, principal of $14,733 and accrued interest of $907 ($15,640) was converted into 230,000,000 shares of common stock. The outstanding balances at September 30, 2018 and December 31, 2017 were $19,393 and $34,126, respectively with accrued interest of $1,000 and $604 at September 30, 2018 and December 31, 2017, respectively. During the year ended December 31, 2014, the Company drew down an additional $314,703. During the nine months ended September 30, 2018, there were no conversions. The outstanding balances at September 30, 2018 and December 31, 2017 were $329,175 and $329,175 respectively, with accrued interest of $88,998 and $71,015 at September 30, 2018 and December 31, 2017, respectively. KBM Worldwide On February 4 2015, the Company entered into an 8% convertible note in the amount of $54,000 with KBM Worldwide, Inc. (“KBM Worldwide”). The principal and accrued interest is payable on or before November 6, 2015. The Company continues to negotiate with the lender. At the option of the Company, but not before six months from the date of issuance, the holder may elect to convert all or part of such note into the Company’s common stock. The note is convertible into shares of the Company’s common stock at a price of 60% of the average of the three lowest trading prices during the 10 days prior to the date of conversion or $0.00009, whichever is greater. During the nine months ended September 30, 2018, principal of $3,480 and accrued interest of $1,520 ($5,000) was converted into 55,555,556 shares of common stock. The outstanding balances at September 30, 2018 and December 31, 2017 were $-0- and $3,480, respectively, with accrued interest of $19,483 and $9,721 at September 30, 2018 and December 31, 2017, respectively. Vis Vires Group, Inc. On March 11, 2015, the Company entered into an 8% convertible note in the amount of $38,000 with Vis Vires Group, Inc. (“Vis Vires”). The principal and accrued interest is payable on or before November 6, 2015. At the option of the Company, but not before six months from the date of issuance, the holder may elect to convert all or part of the convertible into the Company’s common stock. The note is convertible into shares of the Company’s common stock at a price equal to 60% of the average of the three lowest trading prices during the 10 days prior to the date of conversion or $0.00009, whichever is greater. During the nine months ended September 30, 2018, there were no conversions. The outstanding balance at September 30, 2018 and December 31, 2017 was $38,000 with accrued interest of $10,902 and $8,622 at September 30, 2018 and December 31, 2017, respectively. The Company is currently negotiating an extension to this note. On April 30, 2015, the Company entered into an 8% convertible note in the amount of $33,000 with Vis Vires. The principal and accrued interest is payable on or before November 6, 2015. At the option of the Company, but not before six months from the date of issuance, the holder may elect to convert all or part of the convertible into the Company’s common stock. The note is convertible into shares of the Company’s common stock at a price equal to 60% of the average of the three lowest trading prices during the 10 days prior to the date of conversion or $0.00009, whichever is greater. During the nine months ended September 30, 2018, there were no conversions. The outstanding balance at September 30, 2018 and December 31, 2017 was $33,000 with accrued interest of $8,984 and $7,004 at September 30, 2018 and December 31, 2017, respectively. The Company is currently negotiating an extension to this note. As of September 30, 2018 and December 31, 2017, total convertible debt was $419,568 and $437,781, respectively,

Derivative Liability Disclosure

Derivative Liability Disclosure	9 Months Ended
	Sep. 30, 2018
Notes
Derivative Liability Disclosure	Note 8 - Derivative Liability The Company accounts for the fair value of the conversion features of its convertible debt in accordance with ASC Topic No. 815-15 “Derivatives and Hedging; Embedded Derivatives” (“Topic No. 815-15”). Topic No. 815-15 requires the Company to bifurcate and separately account for the conversion features as an embedded derivative contained in the Company’s convertible debt. The Company is required to carry the embedded derivative on its balance sheet at fair value and account for any unrealized change in fair value as a component of results of operations. The Company values the embedded derivatives using the Black-Scholes pricing model. The derivative liability is revalued each reporting period using the Black-Scholes model. As of September 30, 2018 and December 31, 2017, the Company had no derivative liabilities.

Advances From Principal Executi

Advances From Principal Executive Officer and Accrued Interest Disclosure	9 Months Ended
	Sep. 30, 2018
Notes
Advances From Principal Executive Officer and Accrued Interest Disclosure	Note 9 - Advances from Principal Executive Officer and Accrued Interest At December 31, 2017, an amount of $323,855 was reclassified from Bank lines of credit and $2,000 from accounts payable and accrued liabilities to Advances from principal executive officer and accrued interest to reflect the guaranty of these loans by the principal executive officer. The Company also receives periodic advances from its principal executive officer based upon the Company’s cash flow needs. At September 30, 2018 and December 31, 2017 $472,301 and $459,636, respectively, was due to such officer, including accrued interest. Interest expense is accrued at an average annual market rate of interest which was 5.0% and 4.5% at September 30, 2018 and December 31, 2017, respectively. Interest expense due to such officer was $11,788 and $33,788 for the three and nine months ended September 30, 2018 as compared to $6,308 and $17,989 for the three and nine months ended September 30, 2017, respectively. Accrued interest was $139,389 and $104,601 at September 30, 2018 and December 31, 2017, respectively. No terms for repayment have been established. As a result, the amount is classified as a current liability. On September 30, 2018, the Principal Executive Office signed an agreement with the Company extending payment of $244,441 of this amount due until January 31, 2020 as a result of the financial situation of the Company. As such, the $244,441 was classified as a long-term liability and $227,860 was classified as a current liability. Effective February 28, 2010, the Company entered into an employment agreement with its CEO. The agreement, which is for a five year term, provides for an initial base salary of $175,000 per year with a 3% annual increase thereafter (the “Base Salary”). The CEO is also entitled to certain bonuses based on net profits before taxes and other customary benefits, as defined in the agreement. In addition, since it is understood that the Company is employing the CEO during a time of economic decline throughout the U.S. and at times and from time to time, the Company may not be in a position to pay the full amount of Base Salary owed the CEO it is understood and agreed to by the Board, that as long as the Company is unable to pay the CEO the full amount of his Base Salary that the Board shall issue to him, from time to time, an amount of shares that will allow him to remain in possession of fifty-one percent (51%) of the Company’s then outstanding shares of common stock. Such issuances shall be made to the CEO at any time when his total share holdings are reduced to an amount less than fifty-one percent (51%) as a result of issuance of shares of common stock made on behalf of the Company. Effective September 1, 2011, the Company and CEO entered into an Amended and Restated Employment Agreement (the “Amended Agreement”) which primarily retains the term and compensation of the original agreement. The Amended Agreement, however, removes the section which previously provided for the issuance of Company common stock to the CEO, from time to time, when the Company is unable to pay the CEO the full amount of his Base Salary (as defined in the Amended Agreement) which would allow the CEO to maintain a fifty-one percent (51%) share of the Company’s outstanding common stock. However, the CEO does have the right to request all or a portion of his unpaid Base Salary be paid with the Company’s restricted common stock. In addition, the Amended Agreement provides for the issuance of 51 shares of newly authorized Series A Preferred Stock to be issued to the CEO. As defined in the Certificate of Designations, Preferences and Rights of the Series A Preferred Stock, each share of Series A Preferred Stock has voting rights such that the holder of 51 shares of Series A Preferred Stock will effectively maintain majority voting control of the Company. Effective November 3, 2011, the CEO notified the Company that for the one year period, retroactive from April 1, 2011, through December 31, 2012, he would reduce his Base Salary to $100,000. The reduction in base compensation was subsequently extended to December 31, 2013. The CEO is currently deferring his salary to conserve cash. Deferred wages due to the CEO amounted to $755,559 and $628,309 for the periods ended September 30, 2018 and December 31, 2017, respectively. On September 30, 2018, the Principal Executive Office signed an agreement with the Company extending payment of $755,559 until January 31, 2020 as a result of the financial situation of the Company. As such, the $755,559 was classified as a long-term liability. The Company is in process of extending this agreement.

Loan Payable Disclosure

Loan Payable Disclosure	9 Months Ended
	Sep. 30, 2018
Notes
Loan Payable Disclosure	Note 10 - Loan Payable The Company receives periodic advances from an investor based upon the Company’s cash flow needs. There is no written loan agreement between the Company and the lender as the Company is negotiating the terms of the agreement. No repayment terms have yet been established. As a result, the amount is classified as a current liability. During the nine months ended September 30, 2018, the Company borrowed $100,000 from this investor.

Litigation Disclosure

Litigation Disclosure	9 Months Ended
	Sep. 30, 2018
Notes
Litigation Disclosure	Note 11 - Litigation We are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our company or any of our subsidiaries, threatened against or affecting our company, our common stock, any of our subsidiaries or of our companies or our subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies: Principles of Consolidation (Policies)	9 Months Ended
	Sep. 30, 2018
Policies
Principles of Consolidation	Principles of Consolidation The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States, and include the Company and its wholly-owned subsidiary. All significant inter-company accounts and transactions have been eliminated.

Net Loss Per Share Disclosure_

Net Loss Per Share Disclosure: Schedule of Earnings Per Share, Basic and Diluted (Tables)	9 Months Ended
	Sep. 30, 2018
Tables/Schedules
Schedule of Earnings Per Share, Basic and Diluted	Three Months Ended Nine Months Ended September 30, 2018 September 30, 2017 September 30, 2018 September 30, 2018 Basic net income (loss) per share computation: Net income (loss) $ (152,281 $ 32,322 $ (413,467) $ (99,267)) Weighted-average common shares outstanding 4,907,602,947 2,588,323,113 4,833,532,943 2,306,206,458 Basic net income (loss) per share $ (0.00) $ (0.00) $ (0.00) $ (0.00) Diluted net income (loss) per share computation: Net income (loss) $ (152,281) $ 32,322 $ (413,467) $ (92,267) Weighted-average common shares outstanding 4,907,602,947 2,558,323,113 4,833,532,943 2,306,206,458 Incremental shares attributable to the shares issuable upon conversion of convertible debt - 8,002,967,583 - - Total adjusted weighted-average shares 4,907,602,947 10,591,290,696 4,833,532,943 2,306,206,458 Diluted net income (loss) per share $ (0.00) $ (0.00) $ (0.00) $ (0.00)

Bank Lines of Credit Disclosu_2

Bank Lines of Credit Disclosure: Schedule of Line of Credit Facilities (Tables)	9 Months Ended
	Sep. 30, 2018
Tables/Schedules
Schedule of Line of Credit Facilities	September 30, December 31, 2018 2017 The Company had one unsecured credit card, minimum payments of principal and interest are due monthly at the credit card’s annual interest rate. At December 31, 2017, the interest rate charged was approximately 9.3%. $ - $ 14,700 Current maturities included in current liabilities $ - $ 14,700

Going Concern Disclosure (Detai

Going Concern Disclosure (Details) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Details
Accumulated deficit	$ 8,621,565	$ 8,208,098
Convertible debt, net	419,568	437,781
Total stockholders' deficit	$ 672,923	$ 280,096

Net Loss Per Share Disclosure (

Net Loss Per Share Disclosure (Details) - shares	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Details
Antidilutive shares	6,162,876,190	8,002,967,583

Net Loss Per Share Disclosure_2

Net Loss Per Share Disclosure: Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Details
Net income (loss), basic	$ (152,281)	$ 32,322	$ (413,467)	$ (99,267)
Weighted average number of shares outstanding, basic	4,907,602,947	2,588,323,113	4,833,532,943	2,306,206,458
Basic earnings (loss) per share	$ 0	$ 0	$ 0	$ 0
Net income (loss), diluted	$ (152,281)	$ 32,322	$ (413,467)	$ (92,267)
Incremental shares attributable to the assumed exercise of outstanding stock options and warrants	0	8,002,967,583	0	0
Weighted average number of shares outstanding, diluted	4,907,602,947	10,591,290,696	4,833,532,943	2,306,206,458
Diluted earnings (loss) per share	$ 0	$ 0	$ 0	$ 0

Bank Lines of Credit Disclosu_3

Bank Lines of Credit Disclosure (Details)	12 Months Ended
	Dec. 31, 2017USD ($)
From Bank lines of credit
Reclassified to Advances from Principal and Accrued Interest	$ 323,855
From accounts payable and accrued liabilities
Reclassified to Advances from Principal and Accrued Interest	$ 2,000

Bank Lines of Credit Disclosu_4

Bank Lines of Credit Disclosure: Schedule of Line of Credit Facilities (Details) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Details
Bank lines of credit, net	$ 0	$ 14,700

Convertible Debt Disclosure (De

Convertible Debt Disclosure (Details) - USD ($)	9 Months Ended
	Sep. 30, 2018	Dec. 31, 2017	Oct. 17, 2014	Dec. 12, 2012
Convertible debt, net	$ 419,568	$ 437,781
Fife Note December 2012
Convertible note				$ 325,000
Iliad Note October 2014
Convertible note			$ 450,000
Fife, Typenex and Iliad Convertible Debt
Convertible note	19,393	34,126
Amount of debt converted into common stock	$ 15,640
Shares of common stock issued for debt conversion	230,000,000
Accrued interest on note	$ 1,000	604
Fife, Typenex and Iliad- additional 2014
Convertible note	329,175	329,175
Accrued interest on note	88,998	71,015
KBM Worldwide Debt
Convertible note		3,480
Amount of debt converted into common stock	$ 5,000
Shares of common stock issued for debt conversion	55,555,556
Accrued interest on note	$ 19,483	9,721
Vis Vires Group Debt
Convertible note	38,000	38,000
Accrued interest on note	10,902	8,622
Vis Vires Group Debt 2
Convertible note	33,000	33,000
Accrued interest on note	$ 8,984	$ 7,004

Advances From Principal Execu_2

Advances From Principal Executive Officer and Accrued Interest Disclosure (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017	Nov. 03, 2011
Due to related party, long-term	$ 244,441		$ 244,441		$ 0
Due to related party, current	227,860		227,860		459,636
Base salary, per year, CEO (reduced)						$ 100,000
Deferred compensation, CEO, current	0		0		628,309
Deferred compensation, CEO, long-term	755,559		755,559		0
From Bank lines of credit
Reclassified to Advances from Principal and Accrued Interest					323,855
From accounts payable and accrued liabilities
Reclassified to Advances from Principal and Accrued Interest					2,000
Advances from principal executive officer
Due to related party	$ 472,301		$ 472,301		$ 459,636
Due to related party, interest rate	5.00%		5.00%		4.50%
Interest expense, related party debt	$ 11,788	$ 6,308	$ 33,788	$ 17,989
Accrued interest, related party	139,389		139,389		$ 104,601
Due to related party, long-term	244,441		244,441
Due to related party, current	$ 227,860		$ 227,860

Loan Payable Disclosure (Detail

Loan Payable Disclosure (Details) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
Details
Loan payable, current	$ 100,000	$ 0